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OBJECTIVE: There is increasing interest in minimizing respon-
der burden when eliciting health related quality-of-life (HRQoL).
We conducted a systematic review of measurement properties of
two HRQoL instruments: the disease-speciﬁc questionnaire, the
Minnesota Living with Heart Failure questionnaire (MLHFQ)
and the generic questionnaire, (SF-36), in congestive heart failure
(CHF). METHODS: We searched MEDLINE, PubMed, Google
Scholar, American Heart Association and Texas Heart Institute.
Using MESH terms: Minnesota living with heart failure,
MLHFQ, SF-36 and chronic heart failure questionnaire. We
included studies that used SF-36 with MLHFQ. Studies had to
be published in English between 1980 and 2005. We assessed the
following properties: reliability (Cronbach’s alpha, and Pearson’s
correlation), construct validity (longitudinal correlations) using
multi-trait, multi-method matrix (MTMM), within and between
domains for subscales and summary scores and responsiveness
(effect size). RESULTS: Our search rendered 28 references, 15
papers (11 trials and 4 reviews). All except one study revealed
consistent outcome measures in domain correlation, regardless
of whether subscales or summary scores were used. The Cron-
bach’s alpha for the MLHFQ were above 0.8, and ranged from
0.78 to 0.93 for the SF-36. The Pearson’s correlations exhibit
that the emotional domains between the two instruments demon-
strate much lower correlations (ranged from 0.409 to 0.52) com-
pared to that of their physical domains (ranged from 0.54 to
0.72). The effect sizes for the emotional domains, especially for
the SF-36, were lower than that of physical domain. Similar ﬁnd-
ings were also found in using MTMM approach. At the same
time, signiﬁcant correlation between the MLHFQ physical and
the emotional domains found in one study warrants close 
examination. CONCLUSIONS: The measurement properties
MLFHQ and SF-36 in CHF are well documented as independent
measures, however concurrent use illustrated inconsistencies
between similar domains giving one reason to pause when con-
sidering mapping from one instrument to the other.
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OBJECTIVES: Patient knowledge of the risks for hypertension
greatly affects the extent to which population-based primary pre-
ventive strategies can be successfully implemented. The objective
of this study is to assess the determinants of knowledge of the
risks for hypertension in an urban, predominantly African-Amer-
ican hypertensive population. METHODS: Using a 12-item high
blood pressure knowledge questionnaire, patient knowledge in
hypertension was measured at patient enrollment. Predictors of
knowledge include age, race, severity of hypertension gender and
current smoking status. The percentage of correct responses was
calculated for the overall group, and for subgroups deﬁned by
independent variables. We used multiple regression to assess the
effects of independent variables on the knowledge of hyperten-
sion. RESULTS: Out of 125 patients, most are African 
American (82.9%), female (66.7%), younger than 65 years
(72.0%), nonsmoker (82.3%) and with pre-hypertension
(70.4%). The overall mean blood pressure knowledge score was
81.5%, with the range of 0–100%. There were subgroup differ-
ences in the scores with signiﬁcant associations between high
blood pressure knowledge score and hypertension severity and
smoking status. When controlling for other variables, patients
with systolic blood pressure (SBP) higher than 140mmHg were
more likely to have lower scores (p = 0.08), while nonsmokers
tended to have higher score than smokers (p = 0.05). CON-
CLUSIONS: Patients with hypertension exhibit a high level of
high blood pressure knowledge. Lower SBP and non-smoking
status signiﬁcantly predict greater knowledge.
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OBJECTIVES: We evaluated whether pharmacological treat-
ment for erectile dysfunction (ED) had a beneﬁcial change in the
control of blood pressure among men being treated for hyper-
tension in the New England VA Healthcare System (VISN 1).
METHODS: We retrospectively analyzed medical record data
from VISN 1 patients diagnosed with hypertension receiving a
prescription for ED before February 1, 2003 and had at least one
blood pressure measurement before after treatment for ED after
excluding subjects with congestive heart failure, cancer, renal
failure, liver disease, or pulmonary hypertension. We modeled
changes in systolic blood pressure (SBP) and various clinical vari-
ables over a 4 year period using a linear mixed model both
overall and stratiﬁed by baseline SBP. RESULTS: We assessed
6768 men with an average age of 61.6 ± 9.92 prescribed almost
exclusively sildenaﬁl who had 148,997 blood pressure measure-
ments. SBP was signiﬁcantly reduced (“C17.84 and -5.53; both
P < 0.0001) in those with baseline SBP >160 and >140 to °Ü 
160mmHg blood pressure groups. There was no appreciable
change in BP for those with baseline SBP of <140. Likely clini-
cal variables to explain these changes increased after treatment
for ED such as starting blood pressure medications (p < 0.0001)
or greater intensity of blood pressure surveillance as indicated
by more blood pressure measures. CONCLUSIONS: This is the
ﬁrst study of this magnitude using analytical methods enabling
the assessment of thousands of blood pressure measures in order
to demonstrate a favorable association between receiving treat-
ment of a therapy targeted at improving quality of life and its
collateral affect on management of a chronic disease. In this
study limited mostly to men prescribed sildenaﬁl, those with ele-
vated blood pressure experienced dramatic improvements in
blood pressure that appear to be related to increases in clinically
relevant behaviors such as initiation of blood pressure treatment.
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Haute Autorité de Santé, Saint Denis La Plaine, France
OBJECTIVES: To compare the cost-effectiveness of 3 screening
strategies in France (birth cohort of 800,000 children) as evi-
dence for universal screening is scarce because available tests
